(3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C34H52O7 — CID 11490032

IUPAC(3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
SMILESCCC(=O)/C(C)=C\C=C\[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]1OC
InChIInChI=1S/C34H52O7/c1-11-28(35)23(4)15-13-16-24(5)32(37)27(8)33-29(39-9)17-12-14-21(2)18-25(6)31(36)26(7)19-22(3)20-30(40-10)34(38)41-33/h12-17,19-20,24-27,29,31-33,36-37H,11,18H2,1-10H3/b16-13+,17-12+,21-14+,22-19+,23-15-,30-20-/t24-,25-,26-,27+,29+,31+,32+,33-/m1/s1
InChIKeySAZREUFFIIBRJP-UYGLYVEYSA-N
MW572.78 g/mol
LogP6.04
Rot. Bonds9

About (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

(3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one (PubChem CID 11490032) has the molecular formula C34H52O7 and a molecular weight of 572.78 g/mol. Its IUPAC name is (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one.

Molecular Properties

Compound Name(3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
PubChem CID11490032
Molecular FormulaC34H52O7
Molecular Weight572.78 g/mol
Exact Mass572.37
IUPAC Name(3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
SMILESCCC(=O)/C(C)=C\C=C\[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]1OC
InChIInChI=1S/C34H52O7/c1-11-28(35)23(4)15-13-16-24(5)32(37)27(8)33-29(39-9)17-12-14-21(2)18-25(6)31(36)26(7)19-22(3)20-30(40-10)34(38)41-33/h12-17,19-20,24-27,29,31-33,36-37H,11,18H2,1-10H3/b16-13+,17-12+,21-14+,22-19+,23-15-,30-20-/t24-,25-,26-,27+,29+,31+,32+,33-/m1/s1
InChIKeySAZREUFFIIBRJP-UYGLYVEYSA-N
XLogP6.04
TPSA102.29 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500572.78
LogP ≤ 56.04
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one?
The IUPAC name of (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one (CID 11490032) is (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one.
What is the SMILES notation for (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one?
The canonical SMILES for (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one is CCC(=O)/C(C)=C\C=C\[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]1OC.
What is the InChIKey of (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one?
The InChIKey is SAZREUFFIIBRJP-UYGLYVEYSA-N. The full InChI is InChI=1S/C34H52O7/c1-11-28(35)23(4)15-13-16-24(5)32(37)27(8)33-29(39-9)17-12-14-21(2)18-25(6)31(36)26(7)19-22(3)20-30(40-10)34(38)41-33/h12-17,19-20,24-27,29,31-33,36-37H,11,18H2,1-10H3/b16-13+,17-12+,21-14+,22-19+,23-15-,30-20-/t24-,25-,26-,27+,29+,31+,32+,33-/m1/s1.
What are the key properties of (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one?
(3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one has a molecular weight of 572.78 g/mol, XLogP of 6.04, 9 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (3Z,5E,7R,8S,9R,11E,13E,15S,16R)-8-hydroxy-16-[(2S,3S,4R,5E,7Z)-3-hydroxy-4,8-dimethyl-9-oxoundeca-5,7-dien-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one is sourced from PubChem (CID 11490032), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).